Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A specific oxyntomodulin receptor has not been identified, and oxyntomodulin is believed to exert its effects by behaving as a weak agonist at both the GLP-1 and glucagon receptors (55)
Use as suggested or as advised by health provider
Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes-2022
CagriSema showed better glycemic management and weight loss than either of its components as single agents
A healthcare provider must confirm the higher dose is clinically appropriate
After six months: 83.3% of users lost more than 5% body weight
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
